Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections

International Journal of STD and AIDS

Volumn 9, Issue 11, 1998, Pages 683-688

  McBride, M O ^a,d   Fischer, P B ^b   Sumiya, M ^a   McClure, M O ^a   Turner, M W ^c   Skinner, C J ^a   Weber, J N ^a   Summerfield, J A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Bacterial infections; Disease progression; Mannose binding protein; Plasma sampling

Indexed keywords

ACUTE PHASE PROTEIN; MANNOSE BINDING PROTEIN; RESTRICTION ENDONUCLEASE;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SOUTHERN BLOTTING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; BLOTTING, SOUTHERN; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMANS; MANNOSE; MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0031733231     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981921350     Document Type: Article

References (34)

1. Malhotra R, Haurum I, Thiel S, et al. Interaction of Clq receptor with lung surfactant protein A. Eur J Immunol 1992; 22:1437-45
2. Drickamer K. Demonstration of carbohydrate-recognition activity in diverse proteins which share a common primary structure motif. Biochem Soc Trans 1989;17:13-15
3. Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem Tokyo 1983;94:937-47
4. Summerfield JA, Taylor ME. Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochem Biophys Acta 1986;883:197-206
5. Taylor ME, Brickell PM, Craig RK, et al. Structure and evolutional origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989;262:763-71
6. Sastry K, Herman GA, Day L, et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989;170: 1175-89
7. Ikeda K, Sannoh T, Kawasaki N, et al. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987;262:7451-4
8. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J Exp Med 1992;176: 1497-502
9. Malhotra R, Laursen SB, Willis AC, et al. Localization of the receptor binding site in the collectin family of proteins. Biochem J 1993;293:15-19
10. Super M, Thiel S, Lu J, et al. Assocation of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989;2:1236-9
11. Thiel S, Holmskov U, Hviid L, et al. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992;90:31-5
12. Nielsen SL, Andersen PL, Koch C, et al. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol 1995;100:219-22
13. Simiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337:1569-70
14. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992;1:709-15
15. Garred P, Thiel S, Madsen HO, et al. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 1992;90:517-21
16. Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40:37-14
17. Super M, Gillies SD, Foley S, et al. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 1992;2:50-5
18. Kurata H, Cheng Hem, Kozutsumi Y, et al. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin. Biochem Biophys Res Commun 1993;191:1204-10
19. Miller ME, Seals J, Kaye R, et al. A familial, plasma associated defect in phagocytosis. Lancet 1968;ii:60-3
20. Sothill JF, Harvey BAM. Defective opsonization: a common immunity deficiency. Arch Dis Child 1976;51:91-9
21. Richardson VF, Larcher VF, Price JF. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch Dis Child 1983;58:799-802
22. Summerfield IA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-9
23. Ezekowitz RA, Kuhlman M, Groopman JE, et al. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989;169: 185-96
24. Haurum JS, Thiel S, Jones IM, et al. Complement activation upon binding of mannose-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307-13
25. Perricone R, Fontana L, De Carolis C, et al. Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol 1987;70:500-7
26. Senaldi G, Peakman M, McManus T, et al. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 1990;162:1227-32
27. Arai T, Tabona P, Summerfield JA. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. QJM 1993;86:575-82
28. Parkin JM, Helbert M, Hughes CL, Pinching AJ. Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS 1989;3(12):37-9
29. Solder BM, Schulz TF, Hengster P, et al. HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol Lett 1989;22: 135-45
30. Robinson WEJ, Montefiori DC, Mitchell WM. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 1990;175:600-4
31. Robinson EJ, Montefiori DC, Mitchell WM. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1988;1:790-4
32. Boyer V, Desgranges C, Trabaud MA, et al. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med 1991;173:1151-8
33. Reisinger EC, Vogetseder W, Berzow D, et al. Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS 1990;4:961-5
34. Spear GT, Sullivan BL, Landay AL, et al. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J Virol 1990;64:5869-73